vs

Side-by-side financial comparison of Affirm Holdings, Inc. (AFRM) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.

Affirm Holdings, Inc. is the larger business by last-quarter revenue ($401.4M vs $207.8M, roughly 1.9× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 32.3%, a 25.1% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $118.0M).

Affirm Holdings, Inc. is an American financial technology company and a point-of-sale lender. Founded in 2012 by PayPal co-founder Max Levchin, it is the largest U.S. based buy now, pay later (BNPL) financier. As of 2025, Affirm reports nearly 26 million users and processing $37 billion in annual payments.

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

AFRM vs IDYA — Head-to-Head

Bigger by revenue
AFRM
AFRM
1.9× larger
AFRM
$401.4M
$207.8M
IDYA
Higher net margin
IDYA
IDYA
25.1% more per $
IDYA
57.4%
32.3%
AFRM
More free cash flow
IDYA
IDYA
$24.1M more FCF
IDYA
$142.2M
$118.0M
AFRM

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
AFRM
AFRM
IDYA
IDYA
Revenue
$401.4M
$207.8M
Net Profit
$129.6M
$119.2M
Gross Margin
Operating Margin
29.3%
52.2%
Net Margin
32.3%
57.4%
Revenue YoY
32.5%
Net Profit YoY
61.3%
330.1%
EPS (diluted)
$0.37
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AFRM
AFRM
IDYA
IDYA
Q4 25
$401.4M
Q3 25
$320.5M
$207.8M
Q2 25
$306.6M
Q1 25
$272.5M
Q4 24
$303.0M
Q3 24
$231.8M
$0
Q2 24
$224.0M
$0
Q1 24
$195.0M
$0
Net Profit
AFRM
AFRM
IDYA
IDYA
Q4 25
$129.6M
Q3 25
$80.7M
$119.2M
Q2 25
$69.2M
Q1 25
$2.8M
Q4 24
$80.4M
Q3 24
$-100.2M
$-51.8M
Q2 24
$-45.1M
$-52.8M
Q1 24
$-133.9M
$-39.6M
Operating Margin
AFRM
AFRM
IDYA
IDYA
Q4 25
29.3%
Q3 25
19.9%
52.2%
Q2 25
18.9%
Q1 25
-3.1%
Q4 24
-1.4%
Q3 24
-57.2%
Q2 24
-32.8%
Q1 24
-82.5%
Net Margin
AFRM
AFRM
IDYA
IDYA
Q4 25
32.3%
Q3 25
25.2%
57.4%
Q2 25
22.6%
Q1 25
1.0%
Q4 24
26.5%
Q3 24
-43.2%
Q2 24
-20.2%
Q1 24
-68.7%
EPS (diluted)
AFRM
AFRM
IDYA
IDYA
Q4 25
$0.37
Q3 25
$0.23
$1.33
Q2 25
$0.22
Q1 25
$0.01
Q4 24
$0.23
Q3 24
$-0.31
$-0.60
Q2 24
$-0.13
$-0.68
Q1 24
$-0.43
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AFRM
AFRM
IDYA
IDYA
Cash + ST InvestmentsLiquidity on hand
$1.5B
$786.9M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$3.5B
$1.1B
Total Assets
$13.0B
$1.2B
Debt / EquityLower = less leverage
2.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AFRM
AFRM
IDYA
IDYA
Q4 25
$1.5B
Q3 25
$1.4B
$786.9M
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.2B
Q3 24
$1.0B
$920.0M
Q2 24
$1.0B
$701.7M
Q1 24
$1.3B
$698.8M
Total Debt
AFRM
AFRM
IDYA
IDYA
Q4 25
$9.0B
Q3 25
$7.7B
Q2 25
$7.6B
Q1 25
$7.1B
Q4 24
$7.3B
Q3 24
Q2 24
$1.8B
Q1 24
Stockholders' Equity
AFRM
AFRM
IDYA
IDYA
Q4 25
$3.5B
Q3 25
$3.3B
$1.1B
Q2 25
$3.1B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
$1.2B
Q2 24
$2.7B
$931.7M
Q1 24
$2.6B
$935.3M
Total Assets
AFRM
AFRM
IDYA
IDYA
Q4 25
$13.0B
Q3 25
$11.5B
$1.2B
Q2 25
$11.2B
Q1 25
$10.4B
Q4 24
$10.5B
Q3 24
$10.1B
$1.2B
Q2 24
$9.5B
$973.7M
Q1 24
$9.2B
$961.5M
Debt / Equity
AFRM
AFRM
IDYA
IDYA
Q4 25
2.54×
Q3 25
2.35×
Q2 25
2.48×
Q1 25
2.49×
Q4 24
2.62×
Q3 24
Q2 24
0.67×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AFRM
AFRM
IDYA
IDYA
Operating Cash FlowLast quarter
$173.7M
$142.2M
Free Cash FlowOCF − Capex
$118.0M
$142.2M
FCF MarginFCF / Revenue
29.4%
68.4%
Capex IntensityCapex / Revenue
13.9%
0.0%
Cash ConversionOCF / Net Profit
1.34×
1.19×
TTM Free Cash FlowTrailing 4 quarters
$619.1M
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AFRM
AFRM
IDYA
IDYA
Q4 25
$173.7M
Q3 25
$374.6M
$142.2M
Q2 25
$74.6M
Q1 25
$210.4M
Q4 24
$312.0M
Q3 24
$196.9M
$-49.2M
Q2 24
$68.8M
$-32.9M
Q1 24
$208.2M
$-43.8M
Free Cash Flow
AFRM
AFRM
IDYA
IDYA
Q4 25
$118.0M
Q3 25
$320.2M
$142.2M
Q2 25
$23.5M
Q1 25
$157.4M
Q4 24
$268.1M
Q3 24
$152.7M
$-49.7M
Q2 24
$30.5M
$-33.9M
Q1 24
$161.7M
$-45.1M
FCF Margin
AFRM
AFRM
IDYA
IDYA
Q4 25
29.4%
Q3 25
99.9%
68.4%
Q2 25
7.7%
Q1 25
57.7%
Q4 24
88.5%
Q3 24
65.9%
Q2 24
13.6%
Q1 24
82.9%
Capex Intensity
AFRM
AFRM
IDYA
IDYA
Q4 25
13.9%
Q3 25
17.0%
0.0%
Q2 25
16.7%
Q1 25
19.5%
Q4 24
14.5%
Q3 24
19.0%
Q2 24
17.1%
Q1 24
23.8%
Cash Conversion
AFRM
AFRM
IDYA
IDYA
Q4 25
1.34×
Q3 25
4.64×
1.19×
Q2 25
1.08×
Q1 25
75.03×
Q4 24
3.88×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AFRM
AFRM

Merchant Network$328.4M82%
Virtual Card Network$73.0M18%
Commercial Agreement Amazon$1.9M0%

IDYA
IDYA

Segment breakdown not available.

Related Comparisons